BioSpace News Archive

Median Technologies (ALMDT)(Paris:ALMDT), The Imaging Phenomics Company®, announces today the results of a preliminary retrospective study on the evaluation of the severity of hepatic fibrosis in Non-Alcoholic Steatohepatitis (NASH) patients using a new imaging biomarker extracted from MRI/MRE images.

Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference.

Owens & Minor, Inc. announced that the company will participate in the BofA Securities 2020 Leveraged Finance Conference on December 1, 2020.

Sotera Health Company (Nasdaq: SHC) today announced the closing of its initial public offering (“IPO”) of 53,590,000 shares of its common stock at a public offering price of $23.00 per share, for gross proceeds of approximately $1.2 billion, before deducting underwriting discounts and commissions and offering expenses

Combines Codexis’ R&D and commercialization platform with Casdin Capital’s investment expertiseto investin and support innovative early stage life science and synthetic biologytechnology companies

Awardees DC Medical and deepmedi recognized for pioneering efforts leveraging data and health technologies to advance potentially life-saving ideas aimed at improving patient care during the COVID-19 pandemic and beyond.

Hepion Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis, announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock.